The abstract is read at the publisher; the summary is JClub's.
Activating PRKD2 missense variants were found in two families with systemic sclerosis, and they increased kinase activation and TCR signaling in heterozygous knock-in Jurkat cells.
- Why it matters: Systemic sclerosis is heterogeneous and usually sporadic, but familial clustering suggests rare genetic contributors; PRKD2 was prioritized to address this gap.
- What they did: Whole exome sequencing of six two-affected-member families identified 253 genes with rare co-segregating variants, with PRKD2 emerging as one of only three genes seen in two families; activating effects were tested in heterozygous knock-in Jurkat cells and suppressed by a pan-PRKD inhibitor in peripheral blood mononuclear cells.
- The result: PRKD2 rare variant enrichment in a sporadic systemic sclerosis cohort supports relevance to disease pathogenesis and highlights PRKD2-mediated TCR signaling as a potentially targetable pathway.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.